1. Evidence of a decline in transmitted HIV-1 drug resistance in the United Kingdom;AIDS,2007
2. Estimating HIV-1 drug resistance in antiretroviral-treated individuals in the United Kingdom;J Infect Dis,2005
3. Performance of the versant HIV-1 resistance assays for detecting drug resistance in therapy-naïve patients infected with different HIV-1 subtypes;Derdelinckx;FEMS Immunol Med Microbiol,2003
4. Johnson J, Li J, Wei X, Lipscomb J, Smith A, Stone C, et al. Low-frequency mutations substantially increase the prevalence of transmitted drug resistance and greatly strengthen the relationship between resistance mutations and virologic failure. Fourteenth CROI. Los Angeles, California, Feb 25–28; 2007 [poster 639].
5. Huppler Hullsiek KH, Peng G, Simen B, Simons J, Egholm M, Novak R, et al. Virologic success of different strategies for Initial ART regimens is predicted by the type and detection level of minor drug-resistant variant detected by ultra deep sequencing: the CPCRA 058 FIRST Study. Fifteenth CROI; 2008 [abstract 878].